2m 2m 2m 2m 2m 2m 2m
Oramed (ORMP)
NASDAQ
$4.52+$0.04 (+0.98%)
Price as of Oct 02, 2026 5:59 PM EDT- $186.4MMarket Cap
- 91.18%1-Year Change
- BiotechnologyIndustry
Oramed (ORMP)
$4.52+$0.04 (+0.98%)
ORMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.48 | ||
Change | -$0.19 (-4.07%) | ||
Open | $4.65 | ||
High | $4.68 | ||
Low | $4.43 | ||
Previous Close | $4.67 | ||
Volume | 272,601 | ||
30-Day Average Volume | 192,024 | ||
1-Week Change | -6.47% | ||
1-Month Change | -7.63% | ||
1-Year Change | 91.18% | ||
3-Year Change | 84.12% | ||
5-Year Change | -77.04% | ||
Fundamentals | |||
Shares Outstanding | 41.6M | ||
Total Assets | $369.6M | ||
Market Cap | $186.4M | ||
Enterprise Value | $196.1M | ||
Period: QTR TTM FY | |||
Revenue | $97.0M | ||
Net Income | $78.2M | ||
Free Cash Flow | -$202,000.00 | ||
EBIT | $101.6M | ||
EBITDA | $101.6M | ||
Net Working Capital | $42.7M | ||
EPS | $1.84 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | 2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -923 | ||
Price/Operating Cash Flow | -932 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 50.22% | ||
Trailing Annual Dividend Yield | 5.58% | ||
Ex-Dividend Date | 01/16/2026 | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/23/2013 | ||
Earnings & Revenue
Annual Dividend Yield